Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mark G Currie

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation

American Journal of Gastroenterology

Hepatology

Gastroenterology

2012

English

Protective Effects of a Superoxide Dismutase Mimetic and Peroxynitrite Decomposition Catalysts in Endotoxin-Induced Intestinal Damage

British Journal of Pharmacology

Pharmacology

1999

English

Related publications

Clinical Response to Linaclotide at Week 4 Predicts Sustained Response in Irritable Bowel Syndrome With Constipation and Improvements in Digestive and Extra-Digestive Symptoms

Therapeutic Advances in Gastroenterology

Gastroenterology

2019

English

Linaclotide: A New Option for the Treatment of Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation in Adults

Clinical Medicine Insights: Gastroenterology

Gastroenterology

2013

English

Randomized Controlled Trial of a 12-Week Digital Care Program in Improving Low Back Pain

npj Digital Medicine

2019

English

Efficacy and Safety of Tofacitinib as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis: A 12-Week, Randomized, Phase 2 Study

English

PTU-152 Significant Improvements in Abdominal Pain and Bowel Symptoms in a Phase 3 Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C): A European Perspective

Gut

Gastroenterology

2012

English

Randomized Controlled Trial of Home-Based 4-Week tDCS in Chronic Minimally Conscious State

English

Efficacy and Safety of Repaglinide Added to Sitagliptin in Japanese Patients With Type 2 Diabetes: A Randomized 24-Week Open-Label Clinical Trial

English

Efficacy and Safety of a Ready-To-Drink Bowel Preparation for Colonoscopy: A Randomized, Controlled, Non-Inferiority Trial

Therapeutic Advances in Gastroenterology

Gastroenterology

2019

English

Efficacy and Safety of 5-Hydroxytryptamine 3 Receptor Antagonists in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mark G Currie

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation

Protective Effects of a Superoxide Dismutase Mimetic and Peroxynitrite Decomposition Catalysts in Endotoxin-Induced Intestinal Damage

Related publications

Clinical Response to Linaclotide at Week 4 Predicts Sustained Response in Irritable Bowel Syndrome With Constipation and Improvements in Digestive and Extra-Digestive Symptoms

Linaclotide: A New Option for the Treatment of Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation in Adults

Randomized Controlled Trial of a 12-Week Digital Care Program in Improving Low Back Pain

Efficacy and Safety of Tofacitinib as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis: A 12-Week, Randomized, Phase 2 Study

PTU-152 Significant Improvements in Abdominal Pain and Bowel Symptoms in a Phase 3 Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C): A European Perspective

Randomized Controlled Trial of Home-Based 4-Week tDCS in Chronic Minimally Conscious State

Efficacy and Safety of Repaglinide Added to Sitagliptin in Japanese Patients With Type 2 Diabetes: A Randomized 24-Week Open-Label Clinical Trial

Efficacy and Safety of a Ready-To-Drink Bowel Preparation for Colonoscopy: A Randomized, Controlled, Non-Inferiority Trial

Efficacy and Safety of 5-Hydroxytryptamine 3 Receptor Antagonists in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials